Lower maternal PlGF in the third trimester was tied to child ADHD in a University of Iowa cohort, independent of preeclampsia and FGR.
Feature|Articles|May 12, 2026
- May/June 2026
- Volume 42
- Issue 02
Chronic skin conditions linked to bullying, depression, and suicide risk in children, adolescents
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Benjamin P. Saylor, Ron Panarotti
Chronic pediatric skin disorders cause significant stigma, bullying, depression, and suicide risk—conditions often underrecognized and undertreated by physicians.
Advertisement
Advertisement
Pediatric patients with chronic skin diseases—including acne, atopic dermatitis (AD), and psoriasis—face significant and frequently underappreciated risks to their mental health and social well-being, according to findings from several recent studies examining quality of life, stigmatization, and psychiatric comorbidities in this population.1-5
Related to this article
Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
Christina Boull, MD, shares recommendations for infant skin care, including choosing gentle cleansers, avoiding irritants, and supporting the skin barrier.
Topical botanical Cinainu earned FDA Breakthrough Therapy status for AA in patients aged 2+, supported by phase 2/3 RAAINBOW data in children.
Children with FASD given choline before age 6 had 9.1% higher nonverbal IQ and 11.3% better working memory vs placebo 5 years after treatment.
Real-world claims show dupilumab was tied to a 33%-52% lower risk of atopic march progression vs systemic corticosteroids in children with AD.
Once-daily roflumilast cream 0.05% was well tolerated in infants 3 to <24 months with AD, with 34.4% reaching vIGA-AD success at week 4.
Advertisement
Advertisement